Loading...

Proteomics Placements And New Platform Pipeline Will Reshape Long-Term Potential

Published
08 Jan 26
Views
12
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-51.6%
7D
-1.6%

Author's Valuation

US$4.0569.6% undervalued intrinsic discount

AnalystHighTarget Fair Value